Exact Mass: 468.11687500000005
Exact Mass Matches: 468.11687500000005
Found 45 metabolites which its exact mass value is equals to given mass value 468.11687500000005,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
simfibrate
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AB - Fibrates
Catechin-4-ol 3-O-beta-D-galactopyranoside
Leucodelphinidin 3-O-alpha-L-rhamnopyranoside
(2-methoxy-5-hydroxymethyl-phenyl)-1-O-beta-D-(6-O-galloyl)-glucopyranoside|2-methoxy-5-hydroxymethyl-phenyl-1-O-(6-galloyl)-beta-D-glucopyranoside|2-Methoxy-5-hydroxymethyl-phenyl-1-O-(6-galloyl)-??-D-glucopyranoside
1,2,3,4-Tetrahydro-4,6,9-trihydroxy-2,3-epoxy-1,2-biphenazine-4-carboxylic acid
(4-Methoxycarbonylphenyl-2,3,4-tri-O-acetyl-beta-D-glucopyranosid)-uronsaeure-methylester|<4-Methoxycarbonylphenyl-2,3,4-tri-O-acetyl-beta-D-glucopyranosid>-uronsaeure-methylester|Methyl-<4-methoxy-carbonyl-phenyl-2,3,4-tri-O-acetyl-beta-D-glucopyranosid>-uronat
3,4-dihydroxyphenethyl alcohol 4-O-beta-D-(6-O-galloyl)-glucopyranoside|3,4-dihydroxyphenethyl alcohol 4-O-beta-D-(6-O-galloyl)glucopyranoside|4-O-(6-O-Galloyl-beta-D-glucopyranoside)-2-(3,4-Dihydroxyphenyl)ethanol|4-O-(6-O-Gulloyl-??-D-glucopuranoside)-2-(3,4-Dihydroxyphenyl)ethanol
3-Hydroxy,6-O-(3,4,5-trihydroxybenzoyl)-Salidroside|6-O-(3,4,5-Trihydroxybenzoyl)-2-(3,4-Dihydroxyphenyl)ethyl beta-D-glucopy-ranoside
1-(3,4-dihydroxyphenyl)-6-(syringoyl)-beta-D-glucopyranose|dunnianoside G
beta,2,3,4,4,6-hexahydroxy-alpha-(alpha-L-rhamnopyranosyl)dihydrochalcone
HoPhe-Phe4Cl-OH
C24H21ClN2O6 (468.10880760000003)
Phe4Cl-HoPhe-OH
C24H21ClN2O6 (468.10880760000003)
Bis(1,3-dithian-2-ylmethyl) 1,6-hexanediylbiscarbamate
C18H32N2O4S4 (468.12448320000004)
Ferrocene,1,1-(1-methylethylidene)bis[ethyl-
C27H32Fe2 (468.12026519999995)
Fosmanogepix
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C514 - Antifungal Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Parsaclisib hydrochloride
C20H23Cl2FN6O2 (468.12434899999994)
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
simfibrate
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AB - Fibrates
3-[(2-chlorophenyl)methyl]-5-[1-(1-oxo-2-thiophen-2-ylethyl)-4-piperidinyl]-2H-triazolo[4,5-d]pyrimidin-7-one
1-{3-[3-(2-Chloro-benzyl)-7-hydroxy-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl]-piperidin-1-yl}-2-thiophen-2-yl-ethanone
1-(6-Methylpyridin-2-yl)-5-(3-phenoxyphenyl)-4-(thiophene-2-carbonyl)pyrrolidine-2,3-dione
C27H20N2O4S (468.11437200000006)
(1R,2R,5S,6S,7S)-2-(Benzylcarbamoyl)-3-[3-chloro-2-(hydroxymethyl)phenyl]-4-oxo-10-oxa-3-azatricyclo[5.2.1.01,5]dec-8-ene-6-carboxylic acid
C24H21ClN2O6 (468.10880760000003)
Lp-PLA2-IN-1
C21H17F5N4O3 (468.1220751999999)
Lp-PLA2-IN-1 is a potent Lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor. Lp-PLA2-IN-1 has the potential for atherosclerosis, Alzheimer's disease research[1].